DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 -4.66 -0.10%
S&P 500 1,978.91 0.57 0.03%
market minute promo

Keryx Biopharmaceuticals (NASDAQ: KERX)

15.00 -0.15 (-0.99%)

REAL-TIME: Last trade at

Extended Hours: $15.00 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

KERX $15.00 -0.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.10
Previous Close $15.15
Daily Range $14.76 - $15.25
52-Week Range $8.29 - $17.46
Market Cap $1.4B
P/E Ratio -21.64
Dividend (Yield) $0.00 (0.0%)
Volume 1,285,964
Average Daily Volume 1,510,737
Current FY EPS -$0.73

Sector

Healthcare

Industry

Drugs

Keryx Biopharmaceuticals (KERX) Description

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Website: http://www.keryx.com/

News & Commentary

3 Catalysts Biotech Investors Must Watch in 2014

Big money is riding on what happens with MannKind, Orexigen, and Keryx over the next few months.

UPDATE: Keryx Announces Zerenex LT Phase 3 Results Shows 'Highly Statistically Significant' Change,

UPDATE: Keryx Announces Zerenex LT Phase 3 Results Shows 'Highly Statistically Significant' Change, Met Primary Endpoint

Seth Klarman Is Top-Performing Guru for First Half 2014

Seth Klarman Tops Guru Scoreboard for First Half 2014

Morning Market Movers

Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains

Keryx Biopharmaceuticals ' Management Presents at 35th Annual Goldman Sachs Global Healthcare Confer

Keryx Biopharmaceuticals ' Management Presents at 35th Annual Goldman Sachs Global Healthcare Conference (Transcript)

Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation

Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's Pre-Market Mover With Heavy Volume Stock

Keryx Ferric Citrate (Zerenex) Could Potentially Save Hemodialysis Patients $1B Annually

Seth Klarman's Baupost: Investment Changes During The First Quarter

See More KERX News...

KERX's Top Competitors

KERX $15.00 (-0.99%)
Current stock: KERX
AMGN $122.65 (-0.15%)
Current stock: AMGN
GILD $91.46 (1.80%)
Current stock: GILD
BIIB $336.39 (0.28%)
Current stock: BIIB